Replicate Bioscience has been awarded a USD 3 million grant from the Gates Foundation to advance the development of self-replicating RNA-based tuberculosis vaccines, expanding its efforts to combat major infectious diseases including TB, HIV, malaria and rabies.
Infectious Disease Research | 20/06/2026 | By News Bureau | 111
iiCON Secures European Funding to Lead Pan-European Network on Infectious Disease Preparedness
iiCON will lead a Europe-wide collaboration bringing together researchers, healthcare experts, policymakers and industry partners to develop coordinated solutions for emerging infectious disease threats.
Infectious Disease Research | 03/06/2026 | By News Bureau
iiCON Secures European Funding to Lead Pan-European Network on Infectious Disease Preparedness
iiCON will lead a Europe-wide collaboration bringing together researchers, healthcare experts, policymakers and industry partners to develop coordinated solutions for emerging infectious disease threats.
Infectious Disease Research | 03/06/2026 | By News Bureau
Phase 2a study findings show RESP-X demonstrated safety, favourable dosing potential and encouraging efficacy signals, supporting further clinical development for respiratory patients colonised with Pseudomonas aeruginosa.
Infectious Disease Research | 25/05/2026 | By News Bureau | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy